Supplementary Figure from A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Authors:
- Ming-Ming HeMHMing-Ming He
- Jian XiaoJXJian Xiao
- Yan-Qiao ZhangYZYan-Qiao Zhang
- Xiang-Lin YuanXYXiang-Lin Yuan
- Wei-Jia FangWFWei-Jia Fang
- Wei WangWWWei Wang
- Xiao-Hua HuXHXiao-Hua Hu
- Zhi-Gang MaZMZhi-Gang Ma
- Yi-Chen YaoYYYi-Chen Yao
- Zhi-Xiang ZhuangZZZhi-Xiang Zhuang
- Fu-Xiang ZhouFZFu-Xiang Zhou
- Jie-Er YingJYJie-Er Ying
Open Access
- 1 April 2023
- other
- Published by American Association for Cancer Research (AACR)